Inspire Medical系统 INSP 深 沪
已收盘 01-30 16:00:00 美东时间
75.78
-2.760
-3.51%
华盛通- 最 高79.98
- 今 开79.59
- 成交量 134.73万股
- 最 低 74.99
- 昨 收 78.54
- 总市值 22.41亿
- 52周最高 197.75
- 市盈率 静 43.26
- 换手率 0.00%
- 52周最低 70.77
- 委 比 63.33%
- 总股本 2957.43万
- 历史最高 330.00
- 量 比 0.95
- 振 幅 6.35%
- 历史最低 22.50
- 每 手 1
- 风险率 36.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
RBC Capital Downgrades Inspire Medical Systems to Sector Perform, Lowers Price Target to $90
RBC Capital analyst Shagun Singh downgrades Inspire Medical Systems (NYSE:INSP) from Outperform to Sector Perform and lowers the price target from $175 to $90.
01-27 21:08
Russell 2000 Extends Records, Meta Jumps 5%: What's Moving Markets Thursday?
U.S. stocks surged midday Thursday as strong GDP data pushed the Russell 2000 to record highs and investors shrugged off tariff and geopolitical fears.
01-23 04:06
美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
Wells Fargo Maintains Overweight on Inspire Medical Systems, Lowers Price Target to $145
Wells Fargo analyst Larry Biegelsen maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and lowers the price target from $160 to $145.
01-14 23:23
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
Inspire Medical Systems will release its Q4 and full-year 2025 financial results on February 11, followed by a conference call at 5:00 p.m. ET. A webcast will be available for listening, and participants wanting to ask questions must register in advance. The call will be replayed on the Investor Relations website approximately two hours after the event and archived for two weeks.
01-07 13:00
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Inspire Medical Systems to present at J.P. Morgan Healthcare Conference on January 12, 2026, discussing its innovative minimally invasive solutions for obstructive sleep apnea. The live webcast will be available at the provided link, and a replay will be accessible on their Investor website for two weeks post-presentation.
2025-12-29 13:00
美股大行评级 | 潜在涨幅63.56%！拜玛林制药获Truist Securities升目标价至100美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持拜玛林制药"买入"评级，目标价从80美元升至100美元；HC Wainwright & Co.：维持Savara"买入"评级，目标价从8美元升至10美元
2025-12-24 11:17
美股周涨跌榜 | 特朗普媒体科技集团周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%
DJT周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%，本周首挂上市，为年内全球最大规模IPO；爱美医疗周涨34.4%，获拜玛林制药48亿美元收购>>
2025-12-20 09:40
